Syncona Ltd to acquire all shares of Freeline Therapeutics at the rate of $6.5/share
LONDON, UK: Syncona Ltd’s newly established portfolio company has entered into an agreement with Freeline Therapeutics Holdings plc to acquire all of the shares of...
Syncona offers $5.00 per share to take full control of Freeline Therapeutics
LONDON, UK: Syncona, a healthcare company that creates, builds and scales global leaders in life science, has made a non-binding offer to buy the rest...